<DOC>
	<DOCNO>NCT00186836</DOCNO>
	<brief_summary>Does vaccinate hemodialysis patient Twinrix® ( combination vaccine hepatitis A hepatitis B ) result difference hepatitis B antibody response comparison monovalent hepatitis B vaccine ? Hepatitis B infection important cause mortality morbidity . Current standard vaccination practice low efficacy level patient ( eg . hemodialysis patient ) susceptible infection . Efficacy two regiment study .</brief_summary>
	<brief_title>Efficacy Study Combined Hepatitis A Hepatitis B Vaccine Protect Against Hepatitis B Hemodialysis Patients</brief_title>
	<detailed_description>Hepatitis B virus ( HBV ) human pathogen cause acute chronic liver infection . Immunosuppression may associate frequent persistent infection HBV infection renal dialysis patient become chronic . The route transmission virus well establish ; direct percutaneous inoculation virus via exchange contaminate blood , blood product , body fluid , hemodialysis . The Center Diseases Control Prevention ( CDC ) recommend immunization high-risk group , include hemodialysis patient . Ninety ninety five percent healthy , immunocompent adult develop protective anti-hepatitis B surface antibody ( anti-HBs ) primary series hepatitis B vaccination , overall efficacy renal dialysis patient much low . The proportion hemodialysis patient develop seroprotective antibody even high dos vaccination median 64 % ( range : 34-88 % ) . Reports suggest combine vaccination hepatitis B hepatitis A ( Twinrix® : combination vaccine contain inactivate hepatitis A recombinant hepatitis B ) may improve immunogenicity healthy individual . In one study , compare Anti-HBs geometric mean titre ( GMT ) month 6 series , subject receive combine vaccine show statistically significant high response obtain monovalent vaccine . Other study also reflect trend vary point vaccination series . Currently , 426 patient hemodialysis program St. Joseph ’ Healthcare Hamilton 324 ( 76 % ) patient susceptible HBV infection . Our study determine improve immunogenicity observe combined HAV HBV vaccine increase efficacy HBV vaccine hemodialysis patient .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Hemodialysis patient Age great equal 18 Able willing give inform consent Undetectable AntiHBs Ab level Presence hepatitis BsAg , hepatitis BcAb Treatment IVIg ( intravenous immune globulin ) within last 6 month Hypersensitivity component either vaccine Contraindication intramuscular injection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>Hepatitis A</keyword>
	<keyword>Hepatitis B</keyword>
	<keyword>Hemodialysis</keyword>
	<keyword>Vaccine</keyword>
</DOC>